Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Deckers Outdoor
DECK
$12.5B
| $68.5M | 0.04% |
1,140,606
-102,762
| -8% | -$7.04M |
|
477
CALL
Medtronic
MDT
$119B
| $68.4M | 0.04% |
545,500
+347,000
| +175% | +$44.9M |
|
478
CALL
Abbott
ABT
$202B
| $68.3M | 0.04% |
578,600
+343,200
| +146% | +$42.2M |
|
479
Strategy Inc
MSTR
$47.4B
| $68.1M | 0.04% |
1,177,930
+1,068,350
| +975% | +$68.5M |
|
480
Domino's
DPZ
$11.3B
| $68M | 0.04% |
142,575
+136,589
| +2,282% | +$69.2M |
|
481
PUT
Northrop Grumman
NOC
$78.3B
| $67.9M | 0.04% |
188,600
+23,900
| +15% | +$8.64M |
|
482
Cummins
CMI
$80.9B
| $67.9M | 0.04% |
302,264
-262,425
| -46% | -$61.5M |
|
|
P
483
Everpure Inc
P
$36.1B
| $67.7M | 0.04% |
2,691,102
-1,222,366
| -31% | -$27M |
|
484
CALL
Zscaler
ZS
$29.4B
| $67.7M | 0.04% |
258,100
| – | – |
|
485
United Therapeutics
UTHR
$22B
| $67.6M | 0.04% |
366,372
-186,767
| -34% | -$36.8M |
|
486
PUT
iShares Global Clean Energy ETF
ICLN
$2.09B
| $67.3M | 0.04% |
3,109,300
+263,600
| +9% | +$6.01M |
|
487
Bristol-Myers Squibb
BMY
$137B
| $67.3M | 0.04% |
1,136,710
-1,104,596
| -49% | -$72.7M |
|
488
Western Alliance Bancorporation
WAL
$8.69B
| $67.1M | 0.04% |
616,354
+203,960
| +49% | +$19.9M |
|
489
PUT
Wynn Resorts
WYNN
$10.3B
| $67M | 0.04% |
791,100
+126,400
| +19% | +$12.5M |
|
|
SMAR
490
DELISTED
Smartsheet Inc.
SMAR
| $67M | 0.04% |
972,849
+670,895
| +222% | +$49.3M |
|
491
Azenta
AZTA
$1.64B
| $66.8M | 0.04% |
652,587
-366,188
| -36% | -$32.8M |
|
492
Mercado Libre
MELI
$97.5B
| $66.6M | 0.04% |
39,666
+20,553
| +108% | +$35.6M |
|
493
Icon
ICLR
$13.3B
| $66.5M | 0.04% |
253,804
-644,083
| -72% | -$157M |
|
494
CALL
Verizon
VZ
$205B
| $66.4M | 0.04% |
1,229,100
+686,200
| +126% | +$38M |
|
|
AZEK
495
DELISTED
The AZEK Co
AZEK
| $66M | 0.04% |
1,806,214
+1,159,135
| +179% | +$45.1M |
|
496
Five Below
FIVE
$13.8B
| $65.8M | 0.04% |
372,248
+273,140
| +276% | +$54.4M |
|
|
CANO
497
DELISTED
Cano Health, Inc.
CANO
| $65.6M | 0.04% |
51,723
+35,077
| +211% | +$42.5M |
|
498
BioMarin Pharmaceuticals
BMRN
$12.9B
| $65.6M | 0.04% |
848,488
+807,552
| +1,973% | +$63.7M |
|
499
Vontier
VNT
$4.46B
| $65.5M | 0.04% |
1,949,078
+61,176
| +3% | +$2.08M |
|
500
American Financial Group
AFG
$11.9B
| $65.2M | 0.04% |
518,547
-116,764
| -18% | -$15.2M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.